CRIS Current Research Information System

NUVOLA, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.328
NA - Nord America 964
EU - Europa 474
AF - Africa 67
SA - Sud America 53
Continente sconosciuto - Info sul continente non disponibili 50
OC - Oceania 3
Totale 2.939
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 935
SG - Singapore 470
VN - Vietnam 263
CN - Cina 260
IT - Italia 127
HK - Hong Kong 94
DE - Germania 58
BD - Bangladesh 56
SE - Svezia 54
KR - Corea 52
GB - Regno Unito 43
BR - Brasile 41
IN - India 38
FR - Francia 34
NL - Olanda 30
IE - Irlanda 29
FI - Finlandia 27
CI - Costa d'Avorio 25
JO - Giordania 22
CH - Svizzera 20
JP - Giappone 20
BG - Bulgaria 18
CA - Canada 16
PH - Filippine 15
RU - Federazione Russa 12
TG - Togo 12
SC - Seychelles 11
ZA - Sudafrica 10
ID - Indonesia 7
ES - Italia 6
TH - Thailandia 6
PL - Polonia 5
LT - Lituania 4
NG - Nigeria 4
PK - Pakistan 4
TW - Taiwan 4
AR - Argentina 3
AU - Australia 3
HN - Honduras 3
IL - Israele 3
MX - Messico 3
AL - Albania 2
AT - Austria 2
BE - Belgio 2
CL - Cile 2
CO - Colombia 2
CR - Costa Rica 2
IQ - Iraq 2
KG - Kirghizistan 2
PE - Perù 2
SA - Arabia Saudita 2
TR - Turchia 2
UZ - Uzbekistan 2
VE - Venezuela 2
BB - Barbados 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HT - Haiti 1
IR - Iran 1
JM - Giamaica 1
LB - Libano 1
MA - Marocco 1
MK - Macedonia 1
MZ - Mozambico 1
OM - Oman 1
PY - Paraguay 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.890
Salva come PNG Salva come JPEG
Città #
Singapore 378
Ashburn 154
Hong Kong 84
San Jose 83
Hefei 76
Santa Clara 71
Hanoi 53
Ho Chi Minh City 52
Seoul 48
Beijing 44
Council Bluffs 44
Chandler 43
Boardman 32
Dong Ket 30
Dublin 29
Abidjan 25
Fairfield 23
Amman 22
Helsinki 21
Bologna 20
New York 20
Bern 19
Los Angeles 18
Sofia 18
Tokyo 18
Princeton 16
Seattle 16
Woodbridge 15
Buffalo 12
Da Nang 12
Houston 12
Lomé 12
Southend 12
São Paulo 12
Lauterbourg 11
Frankfurt am Main 10
Munich 9
Nuremberg 9
Redondo Beach 9
Rome 9
Wilmington 9
Cambridge 8
Shanghai 8
Bengaluru 7
Brooklyn 7
Guangzhou 7
Hyderabad 7
Moncalieri 7
Turin 7
Atlanta 5
Biên Hòa 5
Chicago 5
City of London 5
Dallas 5
Jakarta 5
London 5
Toronto 5
Turku 5
Abbeville 4
Abeokuta 4
Barnet 4
Can Tho 4
Haiphong 4
Hangzhou 4
Milan 4
Paris 4
Tongling 4
Warsaw 4
Bari 3
Berlin 3
Boston 3
Cape Town 3
Charlotte 3
Des Moines 3
Falkenstein 3
Genoa 3
Hải Dương 3
Johannesburg 3
Manchester 3
Modena 3
Mumbai 3
Phoenix 3
Pune 3
Quảng Ngãi 3
Quận Bình Thạnh 3
Roubaix 3
San Diego 3
Stockholm 3
Sydney 3
Tân Tiến 3
Verona 3
Ann Arbor 2
Augusta 2
Bangkok 2
Bexley 2
Bishkek 2
Boydton 2
Bremen 2
Brunswick 2
Brussels 2
Totale 1.840
Salva come PNG Salva come JPEG
Nome #
Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience 281
Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis 245
Single-agent carboplatin in extensive disease small-cell lung cancer patient with liver failure: A case report within the experience of a single institution 195
Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases 182
Bone Targeting Agents in Patients with Prostate Cancer: General Toxicities and Osteonecrosis of the Jaw 179
Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study 171
A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy 164
Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible? 163
Hypertransaminasemia in metastatic renal cell carcinoma patients receiving immune-based combinations: a meta-analysis 141
Cardiac Toxicity From Afatinib in EGFR-Mutated NSCLC: A Rare But Possible Side Effect 129
PD-(L)1 inhibitors as single-agent or in combination with chemotherapy for advanced, PD-L1-high non-small cell lung cancer: a meta-analysis 124
The molecular characteristics of non‐clear cell renal cell carcinoma: What’s the story morning glory? 118
An update on safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma 111
Development and Management of Massive Subcutaneous Metastases with Unusual Clinical Course from Uterine Leiomyosarcoma 106
Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy 101
An insight on novel molecular pathways in metastatic prostate cancer: A focus on ddr, msi and akt 95
The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines) 88
Guiding treatment selection with immunotherapy compared to targeted therapy agents in patients with metastatic kidney cancer 75
IMpower 132: Is the Second Exception to the Rule No Longer an Exception? 74
Clinical consideration for choosing combination therapies in advanced non-small-cell lung cancer: Age, Eastern Cooperative Organization performance status 2, steroids and antibiotics 74
The dilemma of neoadjuvant and adjuvant therapy in urothelial carcinoma: Will immunotherapy solve the problem? 65
Carboplatin, nab-paclitaxel plus atezolizumab in Impower 130 trial: New weapons beyond controversies 58
Totale 2.939
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.015
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.015
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022109 0 0 0 3 6 4 3 12 12 10 42 17
2022/2023333 12 23 9 16 36 19 19 22 87 12 28 50
2023/2024145 24 25 16 11 11 37 0 6 2 7 4 2
2024/2025542 33 59 45 49 74 24 25 17 12 36 52 116
2025/20261.462 137 135 92 115 207 59 134 41 282 91 65 104
2026/2027204 20 41 63 80 0 0 0 0 0 0 0 0
Totale 2.939